Canada Life’s Precigen PGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $116K | Hold |
20,469
| – | – | ﹤0.01% | 1664 |
|
|
2026
Q1 | $79K | Hold |
20,469
| – | – | ﹤0.01% | 1713 |
|
|
2025
Q4 | $85K | Buy |
+20,469
| New | +$79.2K | ﹤0.01% | 1736 |
|
|
2024
Q4 | – | Sell |
-9,556
| Closed | -$9K | – | 2057 |
|
|
2024
Q3 | $9K | Buy |
9,556
+1,808
| +23% | +$2.28K | ﹤0.01% | 2066 |
|
|
2024
Q2 | $12K | Buy |
7,748
+823
| +12% | +$1.2K | ﹤0.01% | 2082 |
|
|
2024
Q1 | $10K | Buy |
6,925
+905
| +15% | +$1.3K | ﹤0.01% | 2135 |
|
|
2023
Q4 | $8K | Sell |
6,020
-6,369
| -51% | -$7.48K | ﹤0.01% | 2156 |
|
|
2023
Q3 | $18K | Buy |
12,389
+205
| +2% | +$291 | ﹤0.01% | 2153 |
|
|
2023
Q2 | $14K | Sell |
12,184
-1,039
| -8% | -$1.23K | ﹤0.01% | 2216 |
|
|
2023
Q1 | $14K | Buy |
13,223
+3,326
| +34% | +$4.79K | ﹤0.01% | 2273 |
|
|
2022
Q4 | $15K | Buy |
9,897
+741
| +8% | +$1.27K | ﹤0.01% | 2299 |
|
|
2022
Q3 | $20K | Buy |
9,156
+1,068
| +13% | +$2.25K | ﹤0.01% | 2262 |
|
|
2022
Q2 | $11K | Buy |
8,088
+1,129
| +16% | +$1.68K | ﹤0.01% | 2349 |
|
|
2022
Q1 | $15K | Buy |
6,959
+967
| +16% | +$2.35K | ﹤0.01% | 2399 |
|
|
2021
Q4 | $22K | Buy |
5,992
+915
| +18% | +$3.94K | ﹤0.01% | 2362 |
|
|
2021
Q3 | $26K | Hold |
5,077
| – | – | ﹤0.01% | 2386 |
|
|
2021
Q2 | $33K | Hold |
5,077
| – | – | ﹤0.01% | 2382 |
|
|
2021
Q1 | $35K | Hold |
5,077
| – | – | ﹤0.01% | 2406 |
|
|
2020
Q4 | $52K | Hold |
5,077
| – | – | ﹤0.01% | 2263 |
|
|
2020
Q3 | $18K | Hold |
5,077
| – | – | ﹤0.01% | 2462 |
|
|
2020
Q2 | $25K | Buy |
+5,077
| New | +$17.3K | ﹤0.01% | 2447 |
|
|
2020
Q1 | – | Sell |
-5,077
| Closed | -$28K | – | 2760 |
|
|
2019
Q4 | $28K | Buy |
+5,077
| New | +$28.6K | ﹤0.01% | 2429 |
|
|
2019
Q3 | – | Sell |
-3,295
| Closed | -$25K | – | 1953 |
|
|
2019
Q2 | $25K | Sell |
3,295
-10,552
| -76% | -$56.8K | ﹤0.01% | 2561 |
|
|
2019
Q1 | $72K | Buy |
13,847
+7,176
| +108% | +$49.8K | ﹤0.01% | 2170 |
|
|
2018
Q4 | $42K | Hold |
6,671
| – | – | ﹤0.01% | 2434 |
|
|
2018
Q3 | $115K | Hold |
6,671
| – | – | ﹤0.01% | 2148 |
|
|
2018
Q2 | $93K | Hold |
6,671
| – | – | ﹤0.01% | 2212 |
|
|
2018
Q1 | $102K | Hold |
6,671
| – | – | ﹤0.01% | 2161 |
|
|
2017
Q4 | $77K | Hold |
6,671
| – | – | ﹤0.01% | 2250 |
|
|
2017
Q3 | $125K | Hold |
6,671
| – | – | ﹤0.01% | 2089 |
|
|
2017
Q2 | $160K | Hold |
6,671
| – | – | ﹤0.01% | 1975 |
|
|
2017
Q1 | $132K | Sell |
6,671
-60
| -0.9% | -$1.34K | ﹤0.01% | 2021 |
|
|
2016
Q4 | $163K | Hold |
6,731
| – | – | ﹤0.01% | 1968 |
|
|
2016
Q3 | $187K | Hold |
6,731
| – | – | ﹤0.01% | 1921 |
|
|
2016
Q2 | $164K | Hold |
6,731
| – | – | ﹤0.01% | 1934 |
|
|
2016
Q1 | $225K | Buy |
6,731
+2,695
| +67% | +$84.8K | ﹤0.01% | 1248 |
|
|
2015
Q4 | $121K | Hold |
4,036
| – | – | ﹤0.01% | 1631 |
|
|
2015
Q3 | $128K | Hold |
4,036
| – | – | ﹤0.01% | 1526 |
|
|
2015
Q2 | $195K | Sell |
4,036
-149
| -4% | -$6.28K | ﹤0.01% | 1393 |
|
|
2015
Q1 | $181K | Hold |
4,185
| – | – | ﹤0.01% | 1397 |
|
|
2014
Q4 | $110K | Hold |
4,185
| – | – | ﹤0.01% | 1686 |
|
|
2014
Q3 | $75K | Hold |
4,185
| – | – | ﹤0.01% | 1871 |
|
|
2014
Q2 | $100K | Buy |
+4,185
| New | +$84.8K | ﹤0.01% | 1586 |
|
Other funds holding PGEN
PCM
DC
TCM
BCM
IAM
Canada Life's PGEN Position: Q2 2026 in Review
Canada Life held its Precigen (PGEN) position steady in Q2 2026 at 20,469 shares worth $116K. The position accounts for ﹤0.01% of the portfolio, ranked #1664.
Canada Life first reported a position in PGEN in Q2 2014 and has held it in 43 quarters since. The position peaked at $225K in Q1 2016. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.
- Canada Life held 20,469 shares of Precigen worth $116K as of Q2 2026.
- Canada Life left its Precigen share count unchanged in Q2 2026.
- Precigen made up ﹤0.01% of Canada Life's portfolio in Q2 2026, its #1664 holding.
- Canada Life first reported a position in Precigen in Q2 2014 and has held it in 43 quarters since.
- Canada Life's Precigen position peaked at $225K in Q1 2016.
- 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.
Based on Canada Life's 13F filing for Q2 2026, filed 13 Aug 2026.